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Abstract
Platelet concentrates are produced in order to treat bleeding disorders. They can be
provided by apheresis machines or by pooling of buffy coats from four blood
donations. During their manufacturing and storage, morphological alterations of
platelets occur which can be demonstrated by transmission electron microscopy.
Alterations range from slight and reversible changes, such as formation of small cell
protrusions and swelling of the surface-connected open canalicular system, to severe
structural changes, where platelets undergo transitions from discoid to ameboid
shapes as a consequence of platelet activation. These alterations end in delivery of the
contents of platelet granules as well as platelet involution caused by apoptosis and
necrosis processes denoted as the platelet release reaction. Hereby, the involvement
of the network of the open canalicular system, helping to deliver the contents of
platelet granules into the surrounding milieu via pores, is distinctly shown by electron
tomography. As a consequence of platelet activation, a delivery of differently sized
microparticles takes place which is thought to play an important role in the adverse
reactions in some recipients of platelet concentrates. In this article, the formation and
delivery of platelet microparticles is illustrated by electron tomography. Above all,
the ultrastructural features of platelets and megakaryocytes are discussed in the
context of the molecular characteristics of the plasma membrane and organelles
including the different granules and the expression of receptors engaged in signaling
during platelet activation. Starting from the knowledge of the ultrastructure of resting
and activated platelets, a score classification is presented, allowing the evaluation of
different activation stages in a reproducible manner. Examples of evaluations of
platelet concentrates using electron microscopy are briefly reviewed. In the last part,
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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experiments showing the interaction of platelets with bacteria are presented. Using
the tracer ruthenium red, for staining of the plasma membrane and the open
canalicular system of platelets as well as the bacterial wall, the ability of platelets to
adhere and sequestrate bacteria by formation of small aggregates, but also to
incorporate them into compartments of the open canalicular system which are
separated from the surrounding milieu, was shown. In conclusion, electron micro‐
scopy is an appropriate tool for the investigation of the quality of platelet concentrates.
It can efficiently support results on the functional state of platelets obtained by other
methods such as flow cytometry and aggregometry.
Keywords: Platelet concentrates, Quality control, Platelet ultrastructure, Platelet ac‐
tivation, Platelet microparticles, Uptake of bacteria
1. Introduction
Platelet concentrates (PCs) are indispensable biopharmaceuticals for treatment of bleeding
disorders. Indications for PC transfusions are either prophylactic, to prevent hemorrhage in
oncohematology, or therapeutic, using limited platelet (PLT) transfusion to actual bleeding
episodes. They are also applied to treat hematologic patients undergoing surgery and invasive
procedures and disorders of PLT function, such as Glanzmann’s thrombasthenia, Bernard–
Soulier syndrome, Gray and White platelet syndrome, Storage Pool disease, Scott syndrome,
and Disseminated Intravascular Coagulation [1]. Above all, massive PLT transfusions are
indicated for treatment of Refractory Autoimmune Thrombocytopenias [2]. The short storage
period of five days, where PC can be used for transfusion, reflects the high sensitivity of these
cell fragments. This sensitivity is related to the high reactivity of PLTs in respect to their
activation potential but also to their fragility. PCs can be produced by a variety of manufac‐
turing processes which affect more or less the viability and reactivity of PLTs. Several publi‐
cations report on this subject [3–15].
The reactivity of PLTs in the recipient of a PC can only be estimated through the recovery of the
hemostatic balance. To date, no function test is adequate to reliably predict PLT behavior in
vivo  following  transfusion  [16].  A  few laboratory  tests  available  provide  insufficient  or
conflicting results [17]. Therefore, it is obligatory in blood banking to determine the quality of
the PC itself. Nevertheless, it can be assumed that irreversible PLT activation during process‐
ing would impair PLT functionality in vivo. It has been shown that activated PLTs stored for 3
days can provoke activation of T cells, B cells, and monocytes of the recipient [18]. During storage
of PC, activation and release of inflammatory mediators may occur, leading to adverse effects
in transfused patients after cardiac surgery [19]. Above all, the formation of platelet mem‐
brane microparticles (PMPs) contributes to the induction of adverse transfusion reactions by
facilitating cell–cell interactions with cells of the recipient including signal transduction and
even receptor transfer [20]. PMPs could also play a role in anaphylactic transfusion reactions [21].
The Transmission Electron Microscope – Theory and Applications256
Electron microscopy has been used to investigate the complex and highly dynamic structure
of the PLT cytoplasm, including their specific organelles that are primarily formed in the
megakaryocyte (MK) from which they originate.
The ultrastructure of platelets and MKs as well as highlights of their discovery are presented
in Chapter 1 in the form of a historical overview. In Chapter 2, we describe the ultrastructure
of MKs, PLTs in resting and activated forms, as well as PMPs using conventional fixation
methods and advanced methods such as high-pressure fixation, cryosectioning, and cryosub‐
stitution representing state-of-the-art EM techniques. In Chapter 3, we discuss where EM can
efficiently support commonly used routine methods for quality assessment of PCs such as the
flow cytometry and light microscopic methods or aggregometry in respect to the viability and
activation of their particular PLT. In Chapter 4, results on the interaction of bacteria with
platelets are presented. We discuss whether PLT are able to phagocytize bacteria or only
sequestrate them by uptake into the surface-connected open canalicular system or by the
formation of aggregates.
2. Ultrastructure of platelets and megakaryocytes
2.1. Historical overview
Most of the EM reports about PLT were published in the last four decades of the twentieth
century starting from the early 1970s. A remarkable number of reports were published by
James G. White (University of Minnesota, Minneapolis, USA), who focused in his oeuvre on
the ultrastructural investigation of platelets in healthy condition [22–40] but also in several
PLT-associated disorders [41–49]. Marcel Bessis (Centre Nationale de Transfusion Sanguine,
Paris, France) was one of the first who investigated megakaryocytes and PLT among other
blood cells ultrastructurally [50, 51]. In the following years, fine structural features of PLT have
been described, such as the microtubular coil (MTC) providing the discoid shape of non-
activated PLT [40, 52–60], the microfilamentous network providing their contractile apparatus
[29, 53, 55, 61, 62], and the surface-connected open canalicular system (OCS). The latter
represents an invagination of the plasma membrane providing a connection with the outer
milieu via pores at the surface and a two-way channel for uptake of particles and the delivery
of granular contents during activation and degranulation [24, 34, 35, 63–65]. Furthermore, the
dense tubular system (DTS), originating from the endoplasmic reticulum of MKs [66–76] and
small Golgi systems [47, 77–80], has been described. Three types of PLT granules have been
identified morphologically and by histochemical and immunohistochemical methods: dense
granules [22, 80], α-granules [28, 30, 58, 82–85], and lysosomes [72, 78]. Immunogold labeling
allowed the identification of PLT receptors at the plasma membrane and along the invagina‐
tions of the OCS. In this way, Stenberg et al. identified the CD62P receptor (GMP-140) in
unstimulated and in thrombin-activated PLTs [79]. Lewis et al. [80] showed contact sites
leading to aggregated PLTs involving fibrinogen and its receptor GPIIb/IIIa via immunogold
labeling of whole-mount PLT preparations and high-voltage transmission electron microsco‐
py. In these preparations, granulomeres could be easily distinguished from hyalomeres,
separated by a filamentous network. GPIIb/IIIa-positive regions could be identified at cell
contacts, in the surroundings of the granulomere, as well as inside the OCS.
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2.2. Megakaryocytes and the formation of platelets
For understanding the fine structural features in the function of PLTs, dynamic processes with
respect to the rearrangement of organelles, above all of the membranous components, are
important (Figure 1).
Figure 1. Aspects of an MK. In Figure 1a, the delivery of a pro-PLT is shown. The region where pro-PLT (pro-PLT
form) surrounded by the DMS are formed is visible. Note the huge lobulated nucleus (N). Figure 1b: Same aspect at
higher magnification. The delivered pro-PLT is still connected with a network, formed by the DMS. Figure 1c: The as‐
sembly of organelles of newly formed pro-PLTs is indicated by colored contours. Figure 1d: Pleomorphous regions of
the DMS surrounding granules and glycogen aggregates (Gly). Size bars: 2 µm in Figure 1a, 1 µm in Figure 1b, 500 nm
in Figure 1c,d. The samples were routinely prepared by chemical fixation, dehydration, and embedding in Epon, and
70 nm ultrathin sections were viewed under a Tecnai 20 (FEI Co.) at 80 KV acceleration voltage. Digital images were
acquired using an Eagle 4k bottom-mount camera (FEI Co.).
Recently, Machlus and Italiano Jr. reviewed the development of PLTs, starting from MK
development to PLT formation [81]. MKs are the rarest but also the largest cells (50–100 µm in
diameter) of the bone marrow. They mature at the hematopoietic niche (osteoblastic niche)
and travel to the bone marrow sinusoids (vascular niche) in order to deliver 10–20 pro-PLTs
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into the bloodstream. The maturation process, starting from hematopoietic stem cells, is driven
by thrombopoietin which binds to the MK-specific receptor MP-1 [82–84]. Under the influence
of thrombopoietin, the nuclei of MKs enlarge by endomitosis, increasing their DNA content
of 4n, 8n, 16n, 32n, 64n, and even 128n. Obviously, the reason for the augmentation of DNA
in a single nucleus is to provide a sufficient amount of m-RNA in order to form the equipment
for newly formed pro-PLTs while maintaining full functionality of the whole cell [85]. Between
the lobules of the polyploid nucleus, the DMS is formed from the plasma membrane. Required
membranes are provided by the Golgi apparatus via the trans-Golgi network but also by the
endoplasmic reticulum [86]. Using laser confocal microscopy, electron tomography, and
focused ion beam scanning electron microscopy, these authors could show that at all devel‐
opmental stages of MKs, the DMS was in continuity with the PM and that the number of these
connections correlated with nuclear lobulation. They propose that at early MK development
stages, a PM invagination process takes place that resembles cleavage furrow formation.
During MK maturation, the DMS enlarges to a conspicuous network of tubules and cisternae
distributed throughout the whole cytoplasm. The DMS needs support from the cytoskeleton
provided mainly by spectrin; it is essential for the formation of the PM of pro-PLTs [87].
In the terminal maturation process of MKs, long cell extensions, composed of pro-PLTs, extend
into the sinusoidal vessels of the bone marrow, a process also guided by the cytoskeleton. The
pro-PLT elongation is provided mainly by β1-tubulin [88]. In a later publication, this author
described also a new stage of PLT formation; the pre-PLT which can convert into a barbell-like
pro-PLT form, subsequently dividing into two newly formed PLTs [89].
The question how pro-PLTs can pass the wall of the bone marrow sinusoids has been eluci‐
dated by the detection of podosomes which represent micrometer-sized, highly dynamic
circular protrusions of the PM of MK and other cells such as osteoclasts, macrophages,
dendritic cells, and endothelial cells [90, 91]. Podosomes are adhesion domains consisting of
F-actin-rich cores with integrin-associated ring structures. Typical core proteins include
Arp2/3 complex, WASp, and cortactin, whereas integrins, vinculin, talin, paxillin, and myosin
IIA localize to the ring structure [92]. The authors could also demonstrate that MK podosomes
are able to degrade extracellular matrix using matrix metalloproteinases. EM contributed
significantly to visualization and understanding of podosomes. Former publications demon‐
strated the actin filament arrangement in core and network [93, 94]. In more recent works,
podosomes have been investigated in 3D environments [95–98] using super-resolution light
microscopic techniques such as STED (stimulated emission depletion), dSTORM (direct
stochastic optical reconstruction microscopy), and PALM (photoactivated localization
microscopy) that complement electron microscopic capabilities.
2.3. The ultrastructure of platelets
PLTs are the smallest cellular blood components (Figure 2). They are discoid cell fragments
with a remarkable equipment of dynamic organelles but lacking a nucleus. Their diameter
varies between 2 and 3 µm, but their thickness is only less than 1 µm. In human peripheral
blood, the absolute number of PLT ranges from 150,000 to 450,000 per ml. The average lifetime
in the circulation is 5 to 11 days. After this time, they become degraded in the spleen but also
in the liver and in the lung.
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Figure 2. A scheme of a PLT in the equatorial plane (upper image) and in cross section (image at the bottom). Abbrevi‐
ations: DTS dense tubular system, Gly glycogen, α α-granules, δ δ-granules or dense bodies, λ λ-granules or lysosomes, GR
Golgi remnants, MF microfilaments, Mit Mitochondria, OCS open canalicular system, P pores of the OCS, Rib ribosomes.
PLTs circulate under normal health conditions in a quiescent discoid stage that is maintained
by the anti-homeostatic properties of the endothelium that lines the inner wall of the entire
vasculature. After vessels are injured due to trauma or pathological conditions such as
atherosclerosis and diabetes, where a degeneration of endothelium takes place, PLTs become
activated and change their shape dramatically acquiring an ameboid form due to the rear‐
rangement of organelles, triggered by microtubules and microfilaments.
An ongoing activation takes place if PLTs adhere to a glass surface. After a few minutes, a
characteristic compartmentalization in a dense central granulomere and a peripheral lucent
hyalomere can be seen already under the light microscope (Figure 3).
Figure 3. Light microscopic picture of glass-adherent PLTs, incubated for 15 min in phosphate buffered saline. Hyalo‐
mere (HM) and granulomere (GM) are clearly visible. Some adherent PLTs show an ameboid shape (AS) as a sign of
activation.
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In TEM, the granulomere is surrounded by a contractile ring of cytoskeleton elements. The
granulomere contains not only different species of granules but also parts of the surface-
connected OCS, mitochondria, and glycogen. Parts of the DTS line the marginal cytoskeletal
ring (Figure 4b). Resting discoid PLTs contain a peripheral stabilizing microtubular ring built
up of β-tubulin (Figure 4a). This ring represents a circumferential MTC consisting of one
microtubule wound 8–12 times stabilizing the PLT shape. During PLT activation, the MTC is
primary contracted and then fragmented and dislocated to the newly formed filopodia.
Figure 4. TEM of glass-adherent PLTs, fixed for 5 min (a) and 15 min (b) after incubation. Figure 4a shows the MTC
and in close vicinity the DTS. In Figure 4b, hyalomere and granulomere appear separated by the MTC and can be
clearly distinguished. Abbreviations as in Figure 2.
The DTS triggers the resting stage as well as the transition into the activation process of PLTs.
It originates from the rough endoplasmic reticulum of MK. It has an irregular form, and in
resting PLTs, it is located close to the MTC. Its peroxidase content allows to contrast it via a
diaminobenzidine reaction. In contrast to the OCS, it contains slightly electron-dense amor‐
phous material. Lipid-modifying enzymes such as cyclooxygenase and thromboxane synthe‐
tase catalyze downstream metabolites of the arachidonic acid degradation pathway and the
delivery of thromboxane into the extracellular milieu. The PLT activation is regulated by the
maintenance of calcium storage which is controlled by the action of a membrane-associated
pump (sarcoplasmic reticulum Ca2+ ATPase) and by the action of the second messenger cAMP
that initiates the delivery of Ca++ into the cytosol inducing PLT activation.
As mentioned above, PLTs are interlaminated by the OCS originating from the DMS of MKs
and are connected as well with the outer milieu via pores (Figure 5).
The cytoplasm contains α-, δ-, and λ-granules and the dense tubular system which derives
from the endoplasmic reticulum of MKs. Ribosomes and polyribosomes as well as few
mitochondria are also present as equipment remaining from MKs. PLTs also contain often a
high number of accumulated glycogen granules.
alpha-granules contain proteoglycans, hemostasis factors and cofactors (fibrinogen, factors V,
VII, XI, and XIII, kininogens, protein S, and plasminogen), adhesive matrix proteins (fibro‐
nectin (FN), vitronectin (VN), thrombospondin (TSP), von Willebrand factor (vWF), adhesion
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molecules such as GP140 (CD62P), cytokines and chemokines like RANTES and interleukin 8,
as well as several growth factors: TGF-β (transforming growth factor-β), PDGF (platelet-
derived growth factor), ECGF (platelet-derived endothelial growth factor), VEGF (vascular
endothelial growth factor), bFGF (basic fibroblast growth factor), EGF (epidermal growth
factor), and IGF (insulin-like growth factor). In addition, protease inhibitors, albumin and
immunoglobulins are stored in α-granules.
Dense granules (δ-granules) are the smallest ones with a diameter of about 150 nm. Their name
is related to their strongly electron-dense core, surrounded by a clear space enclosed by a single
membrane. These organelles develop in early MKs where they look primarily empty, acquiring
their dense core by incorporation of adenine nucleotides and serotonin during maturation.
They contain a metabolic inert adenine nucleotide pool and store serotonin at concentrations
of about 65 mM. In addition, they contain a high amount of bivalent cations—predominantly
calcium—that is not mobilized in the course of PLT activation.
Lysosomes (λ-granules) exhibit a lower electron density than δ-granules. They contain
lysosomal enzymes playing a role in clot formation but also in antibacterial defense such as
acid proteases and glycoproteases. The lysosomal membrane contains the integral membrane
protein LIMP (CD63) which is transferred to the plasma membrane during PLT activation as
well as the two membrane-associated glycoproteins LAMP-1 and LAMP-2. CD63 is used as a
PLT activation marker and can be routinely demonstrated by flow cytometry using fluorola‐
beled monoclonal antibodies.
The ultrastructure of PLTs as well as the release reaction of granule contents during PLT
activation has been summarized in an excellent review [72].
Figure 5. Electron tomographic 3D model of the OCS showing a pore (P) connecting it with the surrounding milieu.
The DTS is indicated by arrowheads. One virtual slice is shown in background. The electron tomographic acquisition
was performed on a Tecnai 20 (FEI Co., Eindhoven, The Netherlands). Using 200 nm semithin sections, tilt series were
started from –65 ° to +65 ° with 1 ° increment by the help of the Xplore3D software (FEI Co.). Reconstruction of the tilt
series was performed with the IMOD software (Boulder Laboratories, University of Colorado). The model was drawn
using the Amira 4.1 software (Mercury Computer Systems, Merignac, Cedex, France). For abbreviations, see Figure 2.
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In the past two decades, new methodical and technical developments, such as cryofixation
combined with freeze substitution, were applied for the investigation of PLT morphology,
avoiding the problems of chemical fixation-dependent artifacts. In addition, the implementa‐
tion of electron tomography allowed a better understanding of the three-dimensional archi‐
tecture of PLT organelles. In this respect, many views about cytoskeleton and the internal
structure of granules had to be revised [99]. It could be impressively demonstrated that the
OCS and the DTS are highly intertwined, forming close associations in specialized membrane
regions. These authors discerned three subtypes of α-granules based on morphological
features: first, spherical granules with an electron-dense and electron-lucent zone containing
microtubules built up of vWF multimerin elements and a diameter of 12 nm; a second type
containing a multitude of luminal vesicles, 50 nm wide tubular organelles; and a third
population with 18.4 nm crystalline cross striations. Using electron tomography, the authors
could impressively reveal the spatial arrangement of these organelles.
The plasma membrane is the site where a multitude of receptors is present that can interact
with soluble ligands, with cellular counter receptors on other PLTs, on leucocytes, or on
endothelial cells, with molecules of the extracellular matrix but also with pathogens. These
receptors play an important role in inside–outside signaling in the course of PLT activation
and the release reaction. As outlined in a review by Rivera et al. in 2009 [100], many types of
mobile transmembrane receptors are present at the PLT membrane, including many integrins
(αIIbβ3, α2β1, α5β1, α6β1, αVβ3), leucine-rich repeat (LRR) receptors (glycoprotein [GP]
Ib/IX/V, toll-like receptors), G-protein coupled seven-transmembrane receptors (GPCR)
(PAR-1 and PAR-4, thrombin receptors, P2Y1 and P2Y12 ADP receptors, TPα and TPβ (TxA2
receptors), proteins belonging to the immunoglobulin superfamily (GP VI, FcγRIIA), C-type
lectin receptors (P-selectin), tyrosine kinase receptors (thrombopoietin receptor, Gas-6,
ephrins, and Eph kinases), and a miscellaneous of other types (CD63, CD36, P-selectin
glycoprotein ligand 1, TNF receptor type, etc.). Many of these receptors have been character‐
ized using immune electron microscopy [30, 33, 73, 74, 79, 80].
New methods have been developed allowing to share the results from biochemistry, laser
confocal microscopy, and EM to explain the different steps in PLT activation starting from
Ca++  mobilization of the dense tubular system, the degranulation process of  dense gran‐
ules followed by the delivery of the contents of α-granules and lysosomes via docking and
fusion of  the membranes of  granules with the membrane of  the OCS using the SNARE
machinery [101].
2.4. Platelet activation and the release reaction
By EM, PLT changes and signs of activation due to preparatory influences can precisely be
determined and classified. Canizares and coworkers [61] showed the different steps of PLT
activation in detail. Their classifications include six stages: (1) the unaltered discoid form; (2)
the pseudotubular form (very slight activation) when the peripheral MTC disappears, a
pseudotubular membranous structure occurs, and the OCS increases; (3) the membranous
form (slight activation) characterized by pseudomyelinic structures; (4) the saccular stage
(moderate activation) showing an ameboid PLT shape and saccular–tubular reorganizations
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of the OCS and the onset of degranulation; (5) the pseudopodical stage (strong activation)
showing numerous cell projections containing prominent microfibrils present mainly in the
periphery of PLTs. In this stage, the degranulation is already completed; (6) the hyaline stage
refers to the end of the activation process, where shadows of granules and “obscure fibrillar”
structures are visible.
Former concepts describing the dynamics of the MTC have to be revised. It can be demon‐
strated that after exposure of PLTs to agonists, the MTC remains intact. In the course of
activation, the MTC becomes constricted into tight rings around centrally concentrated
granules. During the process of irreversible aggregation and clot retraction, the MTC disinte‐
grate, and groups of individual polymers appear in pseudopods or are oriented in the long
axis of the PLTs. It has been shown that the MTC consists of a single polymer that is wound
in 8–12 coils in the periphery of the cytoplasm [63, 64]. However, three-dimensional cryoelec‐
tron tomographic reconstructions of individually traced microtubules showed that some
circumferential microtubules end at OCS invaginations. They are sometimes incomplete and
occasionally reveal interconnections [65]. The release reaction implicates the fusion of granules
with the OCS where they disintegrate. The fusion event is not easily followed by TEM. In our
image (Figure 6), such a fusion could be demonstrated using rapid cryofixation followed by
cryosubstitution.
Figure 6. PLT showing the delivery of α-granules content into the OCS. Preparation by high-pressure fixation and cry‐
osubstitution into Epon. PLTs from an apheresis PC were sucked into cellulose tubes that were closed at both ends and
subjected to high-pressure fixation. 70 nm ultrathin sections were viewed under a Tecnai 20 electron microscope, and
digital images were acquired using an Eagle 4k bottom-mount camera (FEI Co.). The connection between an α-granule
and the OCS is indicated by the arrow. Abbreviations as in Figure 2.
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2.5. Platelet Microparticles (PMP)
Among other cells such as endothelial and immune cells, PLTs are able to form PMPs which
play a pivotal role in immunology and vascular biology. These particles are thought to be of
significant clinical relevance as they can bind to and interact with macrophages, neutrophil
granulocytes, and endothelial cells [102, 103]. They were first described already in 1967 by
Wolf et al. [104]. PLTs form two types of PMPs differing in size and molecular composition
[105]. One type is relatively large with diameters ranging from 100 nm to 1 µm expressing
GPαIIb-β3, GPIbα, and CD62P and exhibiting the apoptosis marker phosphatidylserine at the
plasma membrane. Therefore, they can be identified via binding of annexin V. The second type
of PMPs, corresponding to ectosomes, is smaller than 100 nm and expresses CD63, a mem‐
brane-spanning protein, present on α-granules which is translocated to the PM during PLT
activation [106, 107]. They interact poorly only weakly with annexin V, do not bind prothrom‐
bin and factor X, and therefore have probably no coagulation function [108]. Among others
[109], these authors separated PMPs by differential centrifugation in order to remove red and
white blood cells as well as PLT followed by ultracentrifugation. PMPs, present in PLT-free
plasma, were absorbed to filmed EM grids and investigated in the TEM after negative staining
[108, 109]. Other groups investigated pellets of PMP, embedded in epoxy resin [106, 107].
In our own studies, pelleted PMPs were trapped in alginate beads, classically embedded, thin
sectioned, and viewed under a TEM (Figure 7).
Figure 7. PMPs embedded in alginate beads. Larger PMPs (l PMP) ≥ 100 nm and aggregated small PMPs could be dis‐
tinguished. Chemical fixation, dehydration, and embedding in Epon. 70 nm ultrathin sections were viewed under a
Tecnai 20 electron microscope, and digital images were acquired using an Eagle 4k bottom-mount camera (FEI Co.).
We were able to visualize the formation of PMPs on glass-adherent PLTs. TEM images showed
that small vesicular elements developed in a protrusion of a PLT. A close association of these
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tightly packed vesicles with the DTS could be observed. The formation of such a multivesicular
sphere and its delivery from the PLT is shown after using electron tomographic reconstruction.
We suggest that microvesicles are delivered from this harboring ball-like structure (Figure 8).
Figure 8. Formation of PLT protrusions containing microvesicles, demonstrated in an electron tomographic 3D model.
Figure 8a shows the formation of a sac, filled with microvesicles; Figure 8b its delivery. Chemical fixation, dehydra‐
tion, and embedding in Epon. 70 nm ultrathin sections were viewed under a Tecnai 20 electron microscope, and digital
images were acquired using an Eagle 4k bottom-mount camera (FEI Co.).
3. Ultrastructural evaluation of PLT activation using TEM is suitable to
monitor PC production
3.1. Production of PC
PCs can be produced by apheresis machines or by pooling of buffy coats obtained from whole
blood donations. There is a long-lasting and long-winded discussion about the advantages
and disadvantages of both methods [110]. To produce PC by apheresis, blood from a healthy
donor is collected and subjected to centrifugation in an apheresis device, where blood cells are
separated according to their density. Blood cells, with exception of PLTs, are reinfused. The
technical features of the most common apheresis machines differ significantly with respect to
stress on PLTs such as centrifugation and shear forces and their duration. In addition, the
degree of contamination with residual leukocytes depends on the particular machine. Some‐
times, apheresis machines produce higher leukocyte rates and have to be filtered using a
leukocyte depletion filter to avoid side effects and complications in the recipient.
Buffy-coat-derived PCs are produced by two-step centrifugation method. Whole blood is
collected into triple bags containing CPD in the primary bag and centrifuged at 4000 × g for 10
min at 22 °C within 12 h. Red blood cells and plasma are separated from the buffy coat fraction
and transferred into satellite containers by using an automated separator. Subsequently, buffy
coats from four different donors and one bag containing either 300 ml plasma from one of the
four donors or PLT additive solution are connected by using a sterile connection device and
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were pooled in one container. Subsequently a 1 l polyolefin bag and a leukocyte reduction
filter are connected. This pool is then centrifuged at 500 × g for 8 min at 22 °C. The supernatant
is squeezed out immediately into the storage bag by means of a plasma extractor [111].
PCs are stored in gas-permeable plastic bags for 5–7 days. In our experience, all manufacturing
processes induce a slight PLT activation which might be also reversible. With lasting storage
time, dead PLTs caused by necrosis but also by apoptosis [112–114] occur. Early stages of
apoptosis can be detected by binding of annexin V to the exposed phosphatidylserine of the
plasma membrane. At the ultrastructural level, this can be visualized by binding of a complex,
consisting of annexin V, a specific antibody, and gold-labeled protein A to the PLT surface
[115]. In late stages of apoptosis and necrosis, the PLT fine structure is then characterized by
the loss in the integrity of membranes and by extraction of the cytoplasm that contains
remnants of granules and cytoskeleton.
In a recent publication [111], we described a method to evaluate the alterations of PLTs at a
single cell level. The method can be carried out easily in routine EM laboratories. A pre-fixation
of PCs was done by mixing 9 ml PC with 1 ml of a 10 % buffered formaldehyde solution (BD
CellFIX™, Becton Dickinson, Vienna, Austria) in order to avoid shape changes of PLT by the
subsequent preparation steps. Immediately after pre-fixation, the samples were centrifuged at
800 x g for 10 min at 22 °C. After discarding the supernatant, the pellet was fixed with 10 ml
of 2.5 % glutaraldehyde (Fluka, Vienna, Austria) in cacodylate buffer, pH 7.2, for 90 min at 4
°C. After fixation, the PLTs were washed twice by centrifugation at 800 x g for 10 min at 4 °C,
transferred to 2 ml Eppendorf vials (Eppendorf AG, Hamburg, Germany), pelleted again, and
fixed with 1 % OsO4 (Fluka) for 90 min, dehydrated in a graded series of ethanol (50, 70, 90, 96
and 100 %) and embedded in Epon (Serva, Heidelberg, Germany). Sections (70–80 nm) of Epon-
embedded cells were cut with an UltraCut UCT ultramicrotome (Leica Inc., Vienna, Austria),
transferred to copper grids, and routinely stained with uranyl acetate and lead citrate. The
sections were viewed either under an EM900 transmission electron microscope (Carl Zeiss,
Oberkochen, Germany), equipped with a 1k wide angle slow-scan CCD camera, allowing
distortion-free images for photomontages (Tröndle, Munich, Germany) at 50 kV or under a
Tecnai 20 transmission electron microscope (FEI Co., Eindhoven, The Netherlands) and a 1k
slow-scan bottom-mount CCD camera (MSC 794, Gatan Inc., Pleasanton, CA, USA) at 80 kV.
The panorama views consisting of eight single digital images at a magnification of 3000x
providing a resolution of about 3700 x 1800 pixels.
• Score 0: unchanged discoid form showing the peripheral MTC in the equatorial plane
(Figure 9a) or in the cross section (Figure 9 b)
• Score 1: formation of filopodia and dilatation of the OCS (Figure 9c)
• Score 2: pronounced shape alterations, centralization of the MTC and proceeding degranu‐
lation (white arrows; Figure 9d)
• Score 3: degeneration with alteration of the plasma membrane and necrosis (Figure 9e)
• In addition, also the formation of aggregates can be visualized (Figure 9f). Note that PLTs
in the center of the aggregate are degranulated. All PLTs are connected among each other
by interdigitating filopodia
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Size bars: 500 nm in Figure 1a–e, 1 µm in Figure 1f. The samples were routinely prepared by
chemical fixation, dehydration, and embedding in Epon, and 70 nm ultrathin sections were
viewed under a Tecnai 20 (FEI Co.) at 80 KV acceleration voltage. Digital images were acquired
using an Eagle 4k bottom-mount camera (FEI Co.).
PLTs representing a particular score value were counted using the analySIS® morphometry
software (Soft Imaging System, Münster, Germany). The score values can be used for statistics
comparing different processing methods using parameter-free rank tests.
The advantage of our score classification consists in the registration of alterations and different
activation stages of PLT caused by the manipulations during production of PCs. It can
distinguish between slight and advanced PLT activation. In addition, the presence of PLT
aggregates is included in the evaluation. Nevertheless, one has to ignore PLTs that are only
marginally sectioned, since in that case no appropriate evaluation is possible. The assembled
images of the photomontages allow further zooming and a detailed analysis of subcellular
features. The MTC and its centralization during PLT activation are only visible in equatorial
Figure 9. Stages of activation and degeneration of PLTs. The morphological evaluation of PLTs in TEM panorama
views is based on a score classification of the individual PLT according to the following criteria:
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sections or in some cross sections. Early changes occur as strong dilatation of the OCS and
formation of surface projections, while strongly activated PLTs show distinct signs of degra‐
nulation and frequently a budding of microparticles and ectosomes.
3.2. Examples on how EM can and has been applied for quality control of PC
EM can be used to examine PLT morphology in relation to different preparation and storage
methods. Integrity as well as activation stages can be immediately monitored at single cell
level. Further functional aspects can be investigated with automatized analytic systems such
as flow cytometry, aggregometry turbometry, etc. The impact of the contribution of EM has
already been pointed out by White and Krumwiede [116]. In this paper, the authors summarize
the morphological features of PLTs and organelles such as MTC, α-granules, and the dense
bodies in PLTs of healthy donors and patients suffering from the Hermansky–Pudlak syn‐
drome and storage pool deficiency disorders as well as giant PLT diseases such as the white
and the gray PLT syndrome. Another publication [117] describes the ultrastructural evaluation
of PC function after intermittent-flow centrifugation apheresis collected from donors by
combined platelet-leukapheresis with hydroxyethyl starch or by plateletpheresis without
starch. The authors found that the PLT morphology was almost unchanged with the exception
of glycogen granules being absent in PLTs isolated in presence of hydroxyethyl starch. They
concluded that the starch did not significantly alter PLT morphology and PLT aggregation.
Forced by the occurrence of bovine spongiform encephalopathies (BSE), caused by prion
infections in the United Kingdom and other countries in the 1990s of the last century, a better
surveillance of blood donations and methods for the production of blood components has been
introduced in most European countries [118]. In the course of these improvements, leucode‐
pletion or better leukoreduction methods have been introduced as a new standard in blood
banking. Even if it is unlikely that prions can be removed by leukoreduction, this procedure
is able to prevent many side effects caused by unwanted cytokine release during storage. In
this context some publications deal with the quality of PLTs after removal of white blood cells
(WBCs). Using EM, no significant PLT alterations were found in surface modified polyester
filters [119], in the filtration system (PL100) [120], as well as by using of the Sepacell PL system
[121]. Similar results were obtained from prestorage WBC reduction filters designed for
leukocyte depletion during the preparation of the pool PC from platelet-rich buffy coats [122].
Interestingly, in filters of WBC-depleted red blood cell concentrates, granulocyte depletion
occurred also by indirect adhesion to activated and spread PLTs [123, 124].
Most of the authors, using EM to investigate PLT vitality, refer to the influence of storage
conditions on the morphological appearance of PLTs [12, 68, 125–130]. Lactate accumulation
may cause a pH fall in PC leading to a reduction of organelles and a progredient destruction
of cell membranes [12, 126]. Storage of buffy-coat-derived PCs can be affected by the presence
of residual WBCs [68] or due to additive solutions, partially replacing plasma. These solutions
provoke increasing PLT activation and increasing chemokine release during storage [127].
Elias et al. described that a good maintenance of PLT ultrastructure could be achieved by
adding a stable synthetic prostacyclin analogue (Iloprost) to the PC [128]. The chemical
composition of storage bags can modify the adhesion of mononuclear cells to the plastic
Transmission Electron Microscopy of Platelets FROM Apheresis and Buffy-Coat-Derived Platelet Concentrates
http://dx.doi.org/10.5772/60673
269
substrate of the PLT storage bag and the release of cytokines. Bags composed of the polyolefin
polymer induce a higher release of IL-1β, TNF-α, IL-6, and IL-8 compared to the single-donor
apheresis polyvinyl chloride polymer platelet bags with the tri-(2-ethylhexyl) trimellitate
(TEHTM) plasticizer. A similar study was carried out using polyvinyl chloride containers
plasticized with tri(2-ethylhexyl) trimellitate (PL 1240 plastic) [129]. Even using the most
advanced storage conditions, the quality of PLTs in PCs decreases significantly with storage
time [127]. For this effect, the high storage temperature of 20 °C as well as a progressive loss
of nutrients in the storage plasma or in the platelet additive solution as well as the accumulation
of toxic metabolites can be taken into consideration. In our experience, the PLT activation is
only slightly enhanced during storage time, while the percentage of necrotic PLTs increases
significantly. In this respect, usually PCs are stored not longer than 5 days.
Ahnadi et al. [130] measured the ex vivo (basal) and in vitro (thrombin-induced) PLT activation
in sodium citrate, ethylenediaminetetraacetic acid (EDTA), and citrate-theophylline-adeno‐
sine-dipyridamol (CTAD) in whole blood specimens. TEM studies verified shape modifica‐
tions and simultaneous retention of granules at early post-venipuncture time periods in CTAD
specimens.
Transfusion of washed PLTs is recommended for patients with history of allergic reactions.
This procedure, commonly performed using neutral, calcium-free Ringer’s acetate (NRA) can
be performed before (prewash) or after storage of PC. Comparing the procedures, Kelley et al.
[131] could not find any fine structural alterations even when the postwash procedure was
carried out only after 6–7 days of storage. In addition, it could be demonstrated that the
chemical structure of storage bags may induce cytokine release leading to alteration of PLT
shape as demonstrated via SEM [132].
Some publications refer to the quality of chilled, frozen, or even lyophilized PLT. It has been
demonstrated that long-term storage of fixed and lyophilized platelets that retain hemostatic
properties after rehydration showed a rather normal ultrastructure [133]. Another option to
increase the storage time is the cryopreservation of human PLTs. It has been shown that
controlled-rate freezing procedure in combination with lower (6 %) Dimethylsulfoxide
(DMSO) concentration resulted in less damage from freezing and higher recovered function
of PLTs as revealed by light and electron microscopic parameters [134]. In contrast, Böck et al.
observed clear signs of beginning cell necrosis after thawing and resuspension in autologous
plasma [135].
An interesting field for EM investigations is the quality control of PC after pathogen inactiva‐
tion and storage of pathogen-inactivated PCs. Advantages and controversies about this
approach including the different techniques have been summarized in [136, 137]. Ultrastruc‐
tural investigations are not available on this subject so far.
3.3. Interaction of PLTs with bacteria
PCs are stored at room temperature to avoid aggregation and injury of the plasma membrane.
Therefore, problems of bacterial contamination and proliferation are increased. An estimation
for bacterial contamination in the United States indicates that 1:1000–1:3000 of PCs leads to
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severe life threatening complications in 1 out of 6 patients [138]. In contaminated PCs, the
following kinds of bacteria could be detected: Clostridium perfringens, Enterobacter cloacae,
Escherichia coli, Flavobacterium spp., Klebsiella oxytoca, Propionibacterium acnes, Salmonella
choleraesuis, Salmonella enterica serotype enteritidis, Salmonella enterica serotype Heidelberg,
Serratia marcescens, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA),
Staphylococcus carnosus, Staphylococcus epidermidis, Staphylococcus lugdunensis, Staphylococcus
spp. coagulase negative, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus viri‐
dans, Yersinia enterocolitica serotype O:3. Bacterial contaminations can be caused by failures in
blood drawing (mainly by insufficient disinfection of donor’s skin), by leak plastic tubes, or
the donor carries bacteria in his/her blood without clinical symptoms.
There exist different opinions about the ability of PLTs to kill bacteria. Even in some cases,
PLTs exhibit adverse reactions for the host by transporting bacteria from the site of infection
to another place in the circulation where they adhere and cause injury [139]. Nevertheless, as
outlined in this review, PLTs are equipped with cell surface receptors reacting directly or
indirectly with counter receptors and molecules at the bacterial wall. Among these PLT
receptors, the fibrinogen receptor GPIIb/IIIa, the von Willebrand factor receptor GPIbα, the Fc
receptor FcγRIIα, complement receptors, and toll-like receptors TLRs (belonging to the innate
immune receptors) are functional. Indirect binding is mediated by fibrinogen, von Willebrand
factor, complement, and IgG. PLTs can also produce bactericide agents such as β-lysins and
PLT microbicidal proteins (PMPs) which do not induce lesions on the bacterial wall but interact
with neutrophil granulocytes and lymphocytes, thrombin-induced PMPs (tPMPs), and their
derivatives termed thrombocidins and kinocidins representing a subset of PMPs being
classical chemokines that have direct microbicidal activity. They possess dual chemokine and
microbicidal effector functions [140]. The host defense against bacteria induces an activated
metabolic status, the change from discoid to ameboid shape with expression of receptors
interacting with injured or infected tissues, the generation of oxygen radicals, as well as the
extension of pseudopodia interacting with microbial pathogens. These changes are managed
by the cytoskeleton which facilitates granule mobilization and degradation leading to the
release of granule contents including host defense peptides.
In our own experiments, using electron tomography, we could impressively show that bacteria
such Escherichia coli and Streptococcus epidermidis could cause their adhesion (Figure 10a),
aggregation (Figure 10b), and engulfment (Figure 10a,c,d). Engulfment of bacteria is achieved
by uptake into the OCS where they can be subsequently sequestered. The separation of parts
of the OCS from the surrounding milieu was verified by the surface-coat-binding of the
electron-dense dye ruthenium red. In sequestered areas of the OCS, both the membrane of the
OCS and the bacterial wall remain unstained (Figure 10c), while in parts of the OCS that are
in continuity with the environment, a distinct decoration of both structures could be found
(Figure 10d). Preliminary studies with the pH-sensitive fluorescent dye pHrodo showed a
decrease of pH in PLTs after engulfment of bacteria. In addition, killing of living bacteria could
be demonstrated by fluorescence microscopy using the LIVE/DEAD® fixable dead cell stain
kit (Life Technologies, Vienna, Austria).
There are different views concerning the phagocytic capacity of PLTs, one favoring the view
of covercytes [141], others supporting the idea of phagocytosis. In this respect, Li et al. [142]
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reported the engulfment and phagocytosis of Porphyromonas gingivalis by ruthenium red
staining. Using enzyme EM methods, as early as 1976, it could be demonstrated that phago‐
cytosis of latex particles by PLTs leads to the formation of acid phosphatase-positive vesicles
and to their killing and degradation [143].
In many countries, pathogen inactivation methods by cross linking of nucleic acids are used
routinely (for reviews, see [144, 145]). There is much emphasis that transfusion-mediated
infections can be avoided by these techniques. Nevertheless, several aspects concerning the
function and recovery of pathogen-inactivated PCs in the recipient are still a matter of
discussion.
4. Conclusion
PLTs are very dynamic cell fragments that display functions, widely exceeding those of blood
coagulation [146]. Electron microscopy, implicating new techniques such as correlative
microscopy, and the various variants of cryotechniques, combined with electron tomography,
allow insights at high resolution, which cannot be achieved with other methods.
Figure 10. Adherent PLTs were stained with ruthenium red as tracer in order to show whether engulfed bacteria
(Staphylococcus epidermidis) are still in contact with the extracellular milieu or separated from it. Figure 10a shows adhe‐
sion (AB) and engulfment of bacteria (EB). Figure 10b demonstrates the ability of PLTs to form aggregates by interdigi‐
tations of filopodia (F) in which bacteria (B) are sequestered. Figure 10c shows completely engulfed bacteria whereby
both the membrane of the OCS (arrowheads) and the bacterial wall remain unstained. In contrast to this image, Figure
10d shows both parts decorated with ruthenium red, indicating that there exists still a communication with the sur‐
rounding milieu. Ultrathin sections were viewed under a Tecnai 20 electron microscope, and digital images were ac‐
quired using an Eagle 4k bottom-mount camera (FEI Co.).
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We would like to emphasize that EM analyses of PCs significantly supplement the routinely
used quality assessment methods monitoring different manufacturing procedures. Methodical
refinements, improving the preparation protocols of EM specimens, such as a wide range of
cryomethods, stabilizing the samples close to the living state, together with electron tomog‐
raphy, 3D-reconstruction and modeling visualize structural details and dynamic processes at
high resolution [99, 147, 148]. Thus new in vitro and in vivo tests of PLT function in transfused
PCs can be efficiently controlled at the EM level. The technique is particularly helpful in the
case a new apheresis system is introduced in a blood bank. EM evaluation of PLT qualities can
significantly supplement the results obtained from commonly used laboratory methods.
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